Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,511 Anemia
clinical trials

Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Methodist Healthcare System of San Antonio/Texas Transplant Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Hospital of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
UCSF (peds)
mi
from
San Francisco, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Unrelated Donor Stem Cell Transplantation
Status: Enrolling
Updated: 12/5/2013
Scripps Green Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Rheumatology, Orthopedics / Podiatry, Reproductive Clinical Trial
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Status: Enrolling, Phase
Updated: 12/31/1969
University of California, San Francisco (UCSF) Children's Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Status: Enrolling
Updated: 11/4/2014
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Status: Enrolling
Updated: 11/4/2014
Presbyterian Hospital Pediatric Sickle Cell Program
mi
from
Charlotte, NC
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Status: Enrolling
Updated: 11/4/2014
University of Missouri Child Health, Division of Pediatric Hematology/Oncology
mi
from
Columbia, MO
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Status: Enrolling
Updated: 11/4/2014
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Status: Enrolling
Updated: 11/4/2014
Sickle Cell Disease and Hemoglobinopathy Clinic Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Status: Enrolling
Updated: 11/4/2014
Children's Hospital of Orange County Sickle Cell Disease Center
mi
from
Orange, CA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Status: Enrolling
Updated: 11/4/2014
All Children's Hospital
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Status: Enrolling
Updated: 11/4/2014
Hematology Oncology P.C.
mi
from
Stamford, CT
Click here to add this to my saved trials
Hematology, Neurology Clinical Trial
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Children's Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Status: Enrolling, Phase II
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
University of Tennessee Cancer Institute
mi
from
Knoxville, TN
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
University of South Alabama Medical Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Kaiser Permanente
mi
from
Vallejo, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other, Reproductive Clinical Trial
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Status: Enrolling, Phase II
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Evaluation of Sickle Cell Liver Disease
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease
Status: Enrolling, Phase I
Updated: 2/12/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Hematology Clinical Trial
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Status: Enrolling, Phase IV
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Glendale, CA
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology, Rheumatology Clinical Trial
Wild-type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Emory University Hospital-Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Anemia Clinical Trial
Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Tripler Army Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
Children's Hospital of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
Our Lady of the Lake Children's Hospital
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
University of Virginia Medical Center
mi
from
Charlottsville, VA
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
Children's Hospital of Michigan, Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
Hurley Research Center
mi
from
Flint, MI
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
Fort Wayne Lutheran Hospital
mi
from
Ft. Wayne, IN
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
University of Louisville/Kosair Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
University of South Alabama
mi
from
Mobile, AL
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
Cohen Children's Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
Children's Hospital of New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
UCSF Benioff Children's Hospital
mi
from
Oakland, CA
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
University of California at Davis Health System
mi
from
Sacramento, CA
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling, Phase III
Updated: 1/9/2016
Howard University
mi
from
Washington DC,
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Intravenous Gammaglobulin for Sickle Cell Pain Crises
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases Clinical Trial
Microvascular and Fibrosis Imaging Study
Status: Enrolling, Phase
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD)
Status: Enrolling, Phase I
Updated: 4/30/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD)
Status: Enrolling, Phase I
Updated: 4/30/2014
UNC Sickle Cell Program
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hematology Clinical Trial
A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Anemia, Iron-Deficiency Clinical Trial
The Benefits of a Preoperative Anemia Management Program
Status: Enrolling
Updated: 8/8/2014
UAB Highlands Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hematology Clinical Trial
Nitrous Oxide Analgesia Vaso-occlusive Crisis
Status: Enrolling, Phase II
Updated: 12/31/1969
New York Presbyterian Morgan Stanley Children's Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Validating Pain Scales in Children and Young Adults
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Sickle Cell Anemia Clinical Trial
Sickle Cell Disease: A Retrospective Chart Review
Status: Enrolling
Updated: 12/15/2011
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Sickle Cell Anemia Clinical Trial
Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
Status: Enrolling
Updated: 9/21/2015
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology Clinical Trial
Microvascular Blood Flow in Sickle Cell Anemia
Status: Enrolling
Updated: 9/3/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Sickle Cell Disease & Thalassemia Clinical Trial
Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Steven and Alexandra Cohen Children's Medical Center of New York
mi
from
New York, NY
Click here to add this to my saved trials
Hematology Clinical Trial
Effects of HQK-1001 in Patients With Sickle Cell Disease
Status: Enrolling
Updated: 1/15/2013
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology Clinical Trial
Effects of HQK-1001 in Patients With Sickle Cell Disease
Status: Enrolling
Updated: 1/15/2013
Howard University Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Anemia of Chronic Kidney Disease Clinical Trial
Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease
Status: Enrolling, Phase II
Updated: 9/19/2013
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Gastroenterology, Hematology, Other, Reproductive Clinical Trial
Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers Study (INSIGHTS Study)
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Hematology Clinical Trial
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 8400118
mi
from
Hartford, CT
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry, Reproductive Clinical Trial
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Pittsburgh Cancer Institute (UPCI)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease
Status: Enrolling
Updated: 10/28/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome
Status: Enrolling, Phase I
Updated: 12/31/1969
UC Irvine Health/Chao Family Comprehensive Cancer Center
mi
from
Orange, CA
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Kings County Hospital Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical University of South Carolina Hospital
mi
from
Charleston, SC
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
MUSC, Investigational Drug Services
mi
from
Charleston, SC
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
The Ohio State University James Comprehensive Cancer Hospital & Solove Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture
Status: Enrolling
Updated: 3/27/2015
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Emory Children's Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Healthcare of Atlanta/Aflac Cancer and Blood Disorders Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Our Lady of the Lake Physician Group-Medical Oncology
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Cincinnati Physicians Company, LLC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
The Ohio State University Investigational Drug Services
mi
from
Columbus, OH
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Wayne State University/Detroit Receiving Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Cook Children's Hematology/Oncology Center-Grapevine
mi
from
Grapevine, TX
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Kosair Charities Pediatric Clinical Research Unit
mi
from
Louisville, KY
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Rutgers Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
UCSF Benioff Children's Hospital Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Staten Island University Hospital
mi
from
Staten Island, NY
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Joseph's Children's Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
MedStar Health Research Institute
mi
from
Washington DC,
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Golisano Children's Hospital of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
1 … 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 … 25